 | | PRD_002211 | | Name: | (2~{S})-~{N}-[(1~{R},2~{S})-1-cyano-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]-3-phenyl-2-[[(~{E})-3-phenylprop-2-enoyl]amino]propanamide | | Formula: | C27 H30 N4 O4 | | Definition date: | 2015-12-09 | | Last modified: | 2015-12-09 |
|
 | | PRD_002208 | | Formula: | C43 H66 N6 O8 | | Definition date: | 2015-12-16 | | Last modified: | 2015-12-16 |
|
 | | PRD_001259 | | Name: | acyclic trypsin inhibitor | | Formula: | C67 H108 N18 O19 S2 | | Definition date: | 2016-01-13 | | Last modified: | 2016-01-13 |
|
 | | PRD_002217 | | Name: | N-(4-carbamimidoylbenzoyl)-beta-alanyl-L-alpha-aspartyl-L-phenylalanine | | Formula: | C24 H27 N5 O7 | | Definition date: | 2016-02-03 | | Last modified: | 2016-02-04 |
|
 | | PRD_002200 | | Name: | N-benzoyl-L-leucyl-L-leucine | | Formula: | C19 H28 N2 O4 | | Definition date: | 2016-02-17 | | Last modified: | 2016-02-17 |
|
 | | PRD_002222 | | Name: | N-(3-bromo-4-methoxybenzene-1-carbonyl)-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | | Formula: | C38 H53 Br N7 O11 P | | Definition date: | 2016-02-24 | | Last modified: | 2016-02-24 |
|
 | | PRD_002156 | | Name: | N-acetyl-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | | Formula: | C24 H45 N5 O6 | | Definition date: | 2016-03-16 | | Last modified: | 2023-11-03 |
|
 | | PRD_001260 | | Name: | PAMK PEPTIDE Inhibitor | | Formula: | C48 H80 N12 O15 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002162 | | Name: | N-[(4-carbamimidamidobutyl)carbamoyl]-L-seryl-N-[(2S)-5-{[amino(iminio)methyl]amino}-1-oxopentan-2-yl]-L-valinamide | | Formula: | C20 H41 N10 O5 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002201 | | Name: | (phenylmethyl) ~{N}-[(8~{S},11~{S},14~{S})-8-(hydroxymethyl)-11-(2-methylpropyl)-5,10,13-tris(oxidanylidene)-1,4,9,12,17,18-hexazabicyclo[14.2.1]nonadeca-16(19),17-dien-14-yl]carbamate | | Formula: | C26 H37 N7 O6 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002202 | | Name: | (phenylmethyl) ~{N}-[(9~{S},12~{S},15~{S})-9-(hydroxymethyl)-12-(2-methylpropyl)-6,11,14-tris(oxidanylidene)-1,5,10,13,18,19-hexazabicyclo[15.2.1]icosa-17(20),18-dien-15-yl]carbamate | | Formula: | C27 H39 N7 O6 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002203 | | Name: | (phenylmethyl) ~{N}-[(12~{S},15~{S},18~{S})-15-(cyclohexylmethyl)-12-(hydroxymethyl)-9,14,17-tris(oxidanylidene)-1,8,13,16,21,22-hexazabicyclo[18.2.1]tricosa-20(23),21-dien-18-yl]carbamate | | Formula: | C33 H49 N7 O6 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002230 | | Name: | L-alpha-aspartyl-6-azaniumyl-L-norleucyl-O-phosphono-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-valyl-N-{(3R)-6-{[amino(iminio)methyl]amino}-1-[2-(methoxycarbonyl)-3,5-dimethylphenyl]-2-oxohexan-3-yl}glycinamide | | Formula: | C48 H81 N12 O18 P | | Definition date: | 2016-05-04 | | Last modified: | 2017-12-15 |
|
 | | PRD_002231 | | Name: | N~2~-{(4R,7S,10R,13R,16R,19S,24R)-19,24-diamino-16-(3-{[amino(iminio)methyl]amino}propyl)-7-(4-azaniumylbutyl)-10-[(1R)-1-hydroxyethyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18,23-hexaoxo-1,2-dithia-5,8,11,14,17,22-hexaazacyclopentacosane-4-carbonyl}-L-leucinamide | | Formula: | C43 H73 N15 O9 S2 | | Definition date: | 2016-06-01 | | Last modified: | 2016-06-01 |
|
 | | PRD_002173 | | Name: | N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | | Formula: | C39 H67 N5 O7 | | Definition date: | 2016-07-27 | | Last modified: | 2023-11-03 |
|
 | | PRD_002175 | | Name: | N,beta,beta-trimethyl-L-phenylalanyl-N-[(3S,4Z)-5-carboxy-2-methylhex-4-en-3-yl]-N,3-dimethyl-L-valinamide | | Formula: | C27 H43 N3 O4 | | Definition date: | 2016-07-27 | | Last modified: | 2016-07-27 |
|
 | | PRD_002204 | | Formula: | C21 H34 N4 O7 | | Definition date: | 2016-07-27 | | Last modified: | 2023-11-03 |
|
 | | PRD_002237 | | Name: | (2R,4R)-4-{[(2-{(1R,3R)-1-(acetyloxy)-4-methyl-3-[methyl(N-{[(2S)-1-methylpiperidin-2-yl]carbonyl}-D-isoleucyl)amino]pentyl}-1,3-thiazol-4-yl)carbonyl]amino}-2-methyl-5-phenylpentanoic acid | | Formula: | C38 H57 N5 O7 S | | Definition date: | 2016-07-27 | | Last modified: | 2016-07-27 |
|
 | | PRD_002186 | | Name: | 6-ammonio-N-[3-(9H-fluoren-9-yl)propanoyl]-L-norleucyl-6-ammonio-L-norleucyl-L-alpha-glutamyl-L-threonyl-L-alpha-glutamyl-L-valine | | Formula: | C47 H70 N8 O13 | | Definition date: | 2016-08-17 | | Last modified: | 2016-08-17 |
|
 | | PRD_002183 | | Name: | (2S,5S,8S,14R,17E)-2-(cyclohexylmethyl)-5-(4-fluorobenzyl)-8-(4-nitrobenzyl)-3,6,9,16,19-pentaoxo-1,4,7,10,15-pentaazacyclononadec-17-ene-14-carboxylic acid | | Formula: | C36 H43 F N6 O9 | | Definition date: | 2016-09-21 | | Last modified: | 2023-11-03 |
|
 | | PRD_002248 | | Name: | (4S,7S,17R)-7-(hydroxymethyl)-4-(2-methylpropyl)-17-pentyl-1-oxa-3,6,11-triazacycloheptadecane-2,5,10-trione | | Formula: | C23 H43 N3 O5 | | Definition date: | 2017-01-11 | | Last modified: | 2017-01-11 |
|
 | | PRD_002249 | | Name: | (4S,7S,17S)-17-(3-chlorophenyl)-7-(hydroxymethyl)-4-(2-methylpropyl)-1-oxa-3,6,11-triazacycloheptadecane-2,5,10-trione | | Formula: | C24 H36 Cl N3 O5 | | Definition date: | 2017-01-11 | | Last modified: | 2017-01-11 |
|
 | | PRD_002253 | | Name: | (2S)-N-{(2S)-3-methoxy-1-[(naphthalen-1-ylmethyl)amino]-1-oxopropan-2-yl}-4-oxo-2-[(3-phenylpropanoyl)amino]-4-(1H-pyrrol-1-yl)butanamide (non-preferred name) | | Formula: | C32 H34 N4 O5 | | Definition date: | 2017-01-11 | | Last modified: | 2023-11-03 |
|
 | | PRD_002254 | | Name: | (2~{S})-~{N}-[(2~{S})-3-methoxy-1-(naphthalen-1-ylmethylamino)-1-oxidanylidene-propan-2-yl]-4-oxidanylidene-2-(3-phenylpropanoylamino)-4-piperidin-1-yl-butanamide | | Formula: | C33 H40 N4 O5 | | Definition date: | 2017-01-11 | | Last modified: | 2023-11-03 |
|
 | | PRD_002256 | | Name: | N-tert-butoxy-N~2~-(5-methyl-1,2-oxazole-3-carbonyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | | Formula: | C28 H35 N5 O7 | | Definition date: | 2017-01-11 | | Last modified: | 2023-11-03 |
|
